A randomized trial of pegylated interferon α-2b plus ribavirin in the retreatment of chronic hepatitis C Academic Article uri icon

Overview

MeSH Major

  • Antiviral Agents
  • Hepatitis C, Chronic
  • Interferon-alpha
  • Ribavirin

abstract

  • Combination therapy with PEG IFN alpha-2b plus RBV is more effective in patients who relapsed after combination standard IFN plus RBV than in nonresponders to either combination therapy or IFN monotherapy. There was no significant effect of dosing regimen.

publication date

  • November 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1111/j.1572-0241.2005.00282.x

PubMed ID

  • 16279900

Additional Document Info

start page

  • 2453

end page

  • 62

volume

  • 100

number

  • 11